Document is current

Article History

Received: 17 January 2025

Revised: 13 February 2025

Accepted: 21 February 2025

First Online: 8 March 2025

Declarations

:

: Prof. Matias-Guiu declares Lectures with fees and associated travel expenses from Roche Farma, Qiagen, Ferrer Internacional, Novartis, Menarini, Biocartis, Agilent-Dako, Leica, Reig Jofre, Sysmex, MSD, Astra-Zeneca, BMS, GSK, Clovis. Eisai, and participation in Advisory Boards for Astra-Zeneca, Lilly, Amgen, GSK, Janssen, Illumina, MSD, Daiichi Sankyo, Inc, Abbvie.Dr. Jordi Temprana Salvador received advisory fees from MSD, lectures with fees and associated travel expenses from Roche and 3dhistech and travel accommodation and expenses, grants from Palex.Pablo Garcia Lopez has received travel accommodation and expenses from Palex.Prof Kammerer-Jacquet declares relevant relationships (grants, advisory fees) with AstraZeneca, MSD and BMS.Prof. Rioux-Leclercq has no relevant conflict of interest.Prof. David Clark has no relevant conflict of interest.Prof. Christian Schürch is a cofounder and shareholder of Vicinity Bio GmbH and is a scientific advisor to and has received research funding from Enable Medicine, Inc., all outside the current work.Prof. Falko Fend has received speaker and advisory board honoraria, travel support or research grants from AetherAI, AstraZeneca, EUSAPharma, StemlineMenarini, and ThermoFisher Scientific.Dr. Sven Mattern has no relevant conflict of interest.Prof. Snead declares that he is a Director and Shareholder of Histofy Ltd. Coventry UK Company number 13732208 and receives an honoraria from Astra Zeneca.N.F. has received honoraria for consulting, advisory role, speaker bureau, travel, and/or research grants from Merck Sharp & Dohme (MSD), Merck, Novartis, AstraZeneca, Roche, Menarini Group, Daiichi Sankyo, GlaxoSmithKline (GSK), Gilead, Sysmex, Veracyte Inc., Sakura, Leica Biosystems, Lilly, Pfizer, ThermoFisher, and Abbvie.Prof. Elena Guerini-Rocco declares relevant relationship (advisory fees, honoraria, travel accommodation and expenses, grants and non-financial support): AstraZeneca, Exact Sciences, GSK, Illumina, MSD, Novartis, Roche, StemlineMenarini, Sophia Genetics, ThermoFisher Scientific.Federico Rojo declares relevant relation relationship (advisory fees, honoraria, travel accommodation and expenses, grants and non-financial support): AstraZeneca, Merck, GSK, BMS, MSD, Novartis, Roche, Menarini-Stemline, AbbVie, Sophia Genetics, Daiichi-Sankyo, Gilead, Pfizer, Lilly.Prof. Marie Brevet is a scientific advisor to Tribun Health & Ummon healthTech and has received research funding from MSD and honoraria from AstraZeneca.Manuel Salto-Tellez is a scientific advisor to Mindpeak and Sonrai Analytics and has received honoraria recently from BMS, MSD, Roche, Sanofi, AstraZeneca, Abbie, and Incyte. He has received grant support from Phillips, Roche, MSD, and Akoya. None of these disclosures are related to this work.Prof. Dei Tos declares advisory fees from Bayer, GSK, Novartis, and Roche and Logibiotech.Elizabeth Sheppard is an employee of AstraZeneca and has stock ownership in the company.Thomas di Maio is an employee of AstraZeneca and has stock ownership in the company.Huw Bannister is an employee of AstraZeneca and has stock ownership in the company.Silvia Ramírez-Peinado is an employee of AstraZeneca.Anastasios Gkiokas is an employee of Alira Health.Ons Ben Dhia is an employee of Alira Health.Nazario Martino is an employee of Alira Health.Mario Arpaia is an employee of Alira Health.